Ex vivo activity of cardiac glycosides in acute leukaemia
- PMID: 21246039
- PMCID: PMC3016342
- DOI: 10.1371/journal.pone.0015718
Ex vivo activity of cardiac glycosides in acute leukaemia
Abstract
Background: Despite years of interest in the anti-cancerous effects of cardiac glycosides (CGs), and numerous studies in vitro and in animals, it has not yet been possible to utilize this potential clinically. Reports have demonstrated promising in vitro effects on different targets as well as a possible therapeutic index/selectivity in vitro and in experimental animals. Recently, however, general inhibition of protein synthesis was suggested as the main mechanism of the anti-cancerous effects of CGs. In addition, evidence of species differences of a magnitude sufficient to explain the results of many studies called for reconsideration of earlier results.
Principal findings: In this report we identified primary B-precursor and T-ALL cells as being particularly susceptible to the cytotoxic effects of CGs. Digitoxin appeared most potent and IC(50) values for several patient samples were at concentrations that may be achieved in the clinic. Significant protein synthesis inhibition at concentrations corresponding to IC(50) was demonstrated in colorectal tumour cell lines moderately resistant to the cytotoxic effects of digoxin and digitoxin, but not in highly sensitive leukaemia cell lines.
Conclusion: It is suggested that further investigation regarding CGs may be focused on diagnoses like T- and B-precursor ALL.
Conflict of interest statement
Figures




Similar articles
-
Cardiac glycosides induce cell death in human cells by inhibiting general protein synthesis.PLoS One. 2009 Dec 16;4(12):e8292. doi: 10.1371/journal.pone.0008292. PLoS One. 2009. PMID: 20016840 Free PMC article.
-
Quo vadis Cardiac Glycoside Research?Toxins (Basel). 2021 May 11;13(5):344. doi: 10.3390/toxins13050344. Toxins (Basel). 2021. PMID: 34064873 Free PMC article. Review.
-
Inhibitory Effects of Digoxin and Digitoxin on Cell Growth in Human Ovarian Cancer Cell Line SKOV-3.Integr Cancer Ther. 2021 Jan-Dec;20:15347354211002662. doi: 10.1177/15347354211002662. Integr Cancer Ther. 2021. PMID: 33736483 Free PMC article.
-
Current status of cardiac glycoside drug interactions.Clin Pharm. 1985 Jul-Aug;4(4):404-13. Clin Pharm. 1985. PMID: 2412751 Review.
-
Cardiac glycosides display selective efficacy for STK11 mutant lung cancer.Sci Rep. 2016 Jul 19;6:29721. doi: 10.1038/srep29721. Sci Rep. 2016. PMID: 27431571 Free PMC article.
Cited by
-
Analysis of proliferation and apoptotic induction by 20 steroid glycosides in 143B osteosarcoma cells in vitro.Cell Prolif. 2015 Oct;48(5):600-10. doi: 10.1111/cpr.12208. Epub 2015 Aug 24. Cell Prolif. 2015. PMID: 26300346 Free PMC article.
-
Anticancer and Antiviral Properties of Cardiac Glycosides: A Review to Explore the Mechanism of Actions.Molecules. 2020 Aug 7;25(16):3596. doi: 10.3390/molecules25163596. Molecules. 2020. PMID: 32784680 Free PMC article. Review.
-
Peruvoside, a Cardiac Glycoside, Induces Primitive Myeloid Leukemia Cell Death.Molecules. 2016 Apr 22;21(4):534. doi: 10.3390/molecules21040534. Molecules. 2016. PMID: 27110755 Free PMC article.
-
Digoxin inhibits PDGF-BB-induced VSMC proliferation and migration through an increase in ILK signaling and attenuates neointima formation following carotid injury.Int J Mol Med. 2015 Oct;36(4):1001-11. doi: 10.3892/ijmm.2015.2320. Epub 2015 Aug 21. Int J Mol Med. 2015. PMID: 26311435 Free PMC article.
-
Digoxin reduces the mutagenic effects of Mitomycin C in human and rodent cell lines.Cytotechnology. 2017 Aug;69(4):699-710. doi: 10.1007/s10616-017-0078-3. Epub 2017 Mar 20. Cytotechnology. 2017. PMID: 28321777 Free PMC article.
References
-
- Stenkvist B. Is digitalis a therapy for breast carcinoma? Oncol Rep. 1999;6:493–496. - PubMed
-
- Stenkvist B. Cardenolides and cancer. Anticancer Drugs. 2001;12:635–638. - PubMed
-
- Stenkvist B, Bengtsson E, Eriksson O, Holmquist J, Nordin B, et al. Cardiac glycosides and breast cancer. Lancet. 1979;1:563. - PubMed
-
- Goldin AG, Safa AR. Digitalis and cancer. Lancet. 1984;1:1134. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical